A steep fall in demand from China drove a 41% decline in MSD Q1 2025 sales of its human papillomavirus (HPV) vaccines Gardasil and Gardasil 9, marking a continued setback for the company’s ...

Merck & Co. said it expects to lose $200 million to already-announced tariffs in 2025 amid an escalating trade war between the US and China, where demand for its blockbuster Gardasil vaccine is ...

The drugmaker is still dealing with the fallout over its HPV vaccine Gardasil in China, where a drop in demand forced it to halt shipments and rescind its previous forecast of $11 billion in ...

Why it matters: Investors have been particularly concerned about demand for HPV vaccine Gardasil in China, with uncertainty around pharmaceutical tariffs also weighing on shares. Gardasil's 41% ($ ...

Athens, Greece – Greece on Wednesday became the first European Union member to take advantage of relaxed spending rules for defence, announcing a 25bn-euro ($27bn) multi-year rearmament programme.

Greece’s prime minister on Tuesday announced €1 billion in financial benefits for lower-income households and the public investment program, after the country became one of the few European ...

ATHENS, April 24 (Reuters) - Greece will deploy a record number of firefighters this year in anticipation of "bad scenarios" ahead, its climate crisis minister said on Thursday, after a succession ...

Unions are seeking increases in salaries and a full return of collective bargaining rights which were scrapped as part of international bailouts during Greece's financial crisis. A nationwide ...

Sales of WELIREG increased 63%, reaching $137 million. Vaccine portfolio performance included GARDASIL sales of $1.3 billion, impacted by a 40% decline in China due to elevated channel inventories.

A slow road trip along mainland Greece’s coastline takes you from one idyllic site to another, from whitewashed villages tucked alongside sea fortresses to quiet beaches just a short drive from ...

1436 GMT – Merck’s struggles with Gardasil aren’t easing up. The drug maker disclosed 1Q sales of the treatment, which prevents cancers caused from the human papillomavirus, declined 41% to ...